Cargando…
Comparison and development of machine learning for thalidomide-induced peripheral neuropathy prediction of refractory Crohn’s disease in Chinese population
BACKGROUND: Thalidomide is an effective treatment for refractory Crohn’s disease (CD). However, thalidomide-induced peripheral neuropathy (TiPN), which has a large individual variation, is a major cause of treatment failure. TiPN is rarely predictable and recognized, especially in CD. It is necessar...
Autores principales: | Mao, Jing, Chao, Kang, Jiang, Fu-Lin, Ye, Xiao-Ping, Yang, Ting, Li, Pan, Zhu, Xia, Hu, Pin-Jin, Zhou, Bai-Jun, Huang, Min, Gao, Xiang, Wang, Xue-Ding |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324537/ https://www.ncbi.nlm.nih.gov/pubmed/37426324 http://dx.doi.org/10.3748/wjg.v29.i24.3855 |
Ejemplares similares
-
Efficacy of thalidomide therapy in pediatric Crohn’s disease with evidence of tuberculosis
por: Wang, Lin, et al.
Publicado: (2017) -
Thalidomide for refractory gastrointestinal bleeding from vascular malformations in patients with significant comorbidities
por: Bayudan, Alexis Mae, et al.
Publicado: (2020) -
High-dose thalidomide increases the risk of peripheral neuropathy in the treatment of ankylosing spondylitis
por: Xue, Hong-xia, et al.
Publicado: (2015) -
Nucleoside diphosphate-linked moiety X-type motif 15 R139C genotypes impact 6-thioguanine nucleotide cut-off levels to predict thiopurine-induced leukopenia in Crohn’s disease patients
por: Zhu, Xia, et al.
Publicado: (2019) -
The efficacy and safety of thalidomide in the treatment of refractory Crohn's disease in adults: a double-center, double-blind, randomized–controlled trial
por: Peng, Xiang, et al.
Publicado: (2022)